These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12841541)

  • 1. Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting.
    Micić D; Sumarac-Dumanović M; Macut Dj; Kendereski A; Zoric S; Popović V; Cvijović G; Dieguez C; Casanueva FF
    J Endocrinol Invest; 2003 Apr; 26(4):333-40. PubMed ID: 12841541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome.
    Micić D; Kendereski A; Popović V; Sumarac M; Zorić S; Macut D; Dieguez C; Casanueva F
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):385-90. PubMed ID: 8959075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
    Cordido F; Alvarez-Castro P; Isidro ML; Casanueva FF; Dieguez C
    Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome.
    Guido M; Romualdi D; Mancini A; Lattanzi F; Villa P; Barini A; Lanzone A; De Marinis L
    Fertil Steril; 2002 Nov; 78(5):994-1000. PubMed ID: 12413983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men.
    Haijma SV; van Dam PS; de Vries WR; Maitimu-Smeele I; Dieguez C; Casanueva FF; Koppeschaar HP
    Eur J Endocrinol; 2005 Apr; 152(4):575-80. PubMed ID: 15817913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.
    Villa P; Fulghesu AM; De Marinis L; Valle D; Mancini A; Pavone V; Caruso A; Lanzone A
    Metabolism; 1997 May; 46(5):538-43. PubMed ID: 9160821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism.
    Villa P; Valle D; Mancini A; De Marinis L; Pavone V; Fulghesu AM; Mancuso S; Lanzone A
    Fertil Steril; 1999 Jan; 71(1):115-21. PubMed ID: 9935127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia.
    Lanzone A; Villa P; Fulghesu AM; Pavone V; Caruso A; Mancuso S
    Hum Reprod; 1995 Jul; 10(7):1653-7. PubMed ID: 8582956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of feeding on growth hormone response to growth hormone-releasing hormone in polycystic ovarian syndrome: relation with body weight and hyperinsulinism.
    Villa P; Soranna L; Mancini A; De Marinis L; Valle D; Mancuso S; Lanzone A
    Hum Reprod; 2001 Mar; 16(3):430-4. PubMed ID: 11228207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
    Muller AF; Janssen JA; Lamberts SW; Bidlingmaier M; Strasburger CJ; Hofland L; van der Lely AJ
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
    Veldhuis JD; Bowers CY
    Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1085-92. PubMed ID: 19240251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome.
    Glintborg D; Støving RK; Hagen C; Hermann AP; Frystyk J; Veldhuis JD; Flyvbjerg A; Andersen M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5605-12. PubMed ID: 16076946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
    Micić D; Macut D; Popović V; Kendereski A; Sumarac-Dumanović M; Zorić S; Dieguez C; Casanueva FF
    Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
    Slowinska-Srzednicka J; Zgliczynski W; Makowska A; Jeske W; Brzezinska A; Soszynski P; Zgliczynski S
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.
    Popovic V; Pekic S; Golubicic I; Doknic M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 2002 May; 87(5):2095-9. PubMed ID: 11994347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
    Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF; Mallo F; Andrade MA; García-Mayor RV; Diéguez C
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3663-7. PubMed ID: 9768681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome.
    Piaditis GP; Kounadi TG; Rangou DB; Trovas GP; Kaklas NA; Tzonou AJ; Chlouverakis CS
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):635-40. PubMed ID: 7634505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.